经颅磁刺激改善脑肿瘤患者术后轻瘫
本多中心研究为两项随机对照试验和三项单臂研究的二次分析,纳入135例脑肿瘤术后新发或进展性上肢轻瘫患者,比较低频对侧导航重复经颅磁刺激(nrTMS)与假刺激联合物理治疗的效果。线性混合模型显示治疗组在BMRC和KPS上优于对照组,FMA差异不明显,术后MRI证实缺血者疗效更强,3个月改善至少一个等级的NNT分别为4(BMRC)和3(KPS)。
要点
- 治疗组7天BMRC的OR为3.28(95%CI 1.08-9.99),3个月OR为2.03(95%CI 0.65-6.39)。
- 治疗组7天KPS平均差异为11(95%CI 2-19),3个月为11(95%CI 2-20)。
- 3个月改善至少一个等级的NNT为4(BMRC)和3(KPS)。
核心结论
- 多中心数据证实nrTMS通过减少经胼胝体抑制对脑肿瘤术后上肢轻瘫有积极治疗效应,NNT相当低,尤其当术后MRI证实缺血时。
研究设计与样本
- 本多中心研究为两项随机对照试验和三项单臂研究的二次分析,纳入135例脑肿瘤术后新发或进展性轻瘫患者(平均年龄53.8岁,60例女性),其中51例来自随机对照试验(30例治疗组、21例假刺激组),84例来自前瞻性单臂研究。
主要发现
- 线性混合模型显示治疗组BMRC在7天时OR为3.28(95%CI 1.08-9.99),3个月时OR为2.03(95%CI 0.65-6.39)。
- 治疗组KPS在7天时平均差异为11(95%CI 2-19),3个月时平均差异为11(95%CI 2-20)。
- FMA差异不明显,7天时平均差异为0.28(95%CI -0.34-0.9),3个月时平均差异为0.14(95%CI -0.52-0.81)。
- 术后MRI证实缺血者治疗效应更强。
- 3个月时观察到至少改善一个等级,整个队列的NNT分别为4(BMRC)和3(KPS)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Recently, reduction of transcallosal inhibition by contralateral navigated repetitive transcranial magnetic stimulation (nrTMS) improved neurorehabilitation of glioma patients with new postoperative paresis. This multicentric study examines the effect of postoperative nrTMS in brain tumor patients to treat surgery-related upper extremity paresis. METHODS: This is a secondary analysis of two randomized and three one-arm studies in brain tumor patients with new/progressive postoperative paresis. Patients underwent either low frequency contralesional nrTMS or sham stimulation followed by physiotherapy. Outcome was assessed on postoperative day 1, 7, and after 3 months using British Medical Research Council score (BMRC), Fugl-Meyer assessment (FMA), Karnofsky Performance Scale (KPS) and National Institutes of Health Stroke Scale (NIHSS). RESULTS: A total of 135 patients (mean age of 53.8 years, 60 women) were included, of whom 51 patients were treated in RCTs (30 treatment group, 21 sham group) and 84 in prospective, single-arm studies. Linear mixed models showed an advantage for the treatment group for the BMRC (7 days: OR 3.28; 95%CI: 1.08-9.99; 3 months: OR 2.03, 95%CI: 0.65-6.39) and KPS (7 days: mean difference (MD) 11, 95%CI: 2-19; 3 months: MD 11, 95%CI: 2-20), less pronounced for the FMA (7 days: MD 0.28, 95%CI: -0.34-0.9; 3 months: MD 0.14, 95%CI: -0.52-0.81). A stronger treatment effect was evident with proven ischemia on the postoperative MRI. To observe an improvement by at least one grade at 3 months, the number needed to treat (NNT) for the entire cohort is 4 (BMRC) and 3 patients (KPS), respectively. CONCLUSION: Our multicenter data confirm the positive treatment effect of nrTMS to reduce transcallosal inhibition with a considerably low NNT - especially if caused by ischemia.
引用
- Rosenstock T, Picht T, Engelhardt M, et al. Improving postsurgical paresis in brain tumor patients by transcranial magnetic stimulation. J Neurooncol. 2025. PMID: 39847143. doi:10.1007/s11060-024-04931-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。